hydrogen sulfide has been researched along with Colonic Neoplasms in 27 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| " The impact of H(2)S on mitochondrial energy metabolism crucially depends on the bioavailability of this gaseous molecule and its interplay with the other two gasotransmitters." | 2.53 | Bioenergetic relevance of hydrogen sulfide and the interplay between gasotransmitters at human cystathionine β-synthase. ( Arese, M; Forte, E; Giuffrè, A; Malagrinò, F; Sarti, P; Vicente, JB, 2016) |
| "The main therapy for colon cancer with liver metastasis is chemotherapy based on 5-fluorouracil combined with targeted drugs." | 1.72 | The CBS-H ( Chen, S; Guo, S; Huang, Z; Li, J; Liu, Y; Wang, P; Wang, X; Yue, T; Zhu, J, 2022) |
| "Roflumilast was administered subcutaneously at two doses (1 and 5 mg/kg/day, from day 28 to 42)." | 1.56 | Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats. ( Ansari, MN; Rastogi, S; Saeedan, AS, 2020) |
| "Analysis of human colon cancer biopsies and patient-matched normal margin mucosa revealed the selective up-regulation of the H2S-producing enzyme cystathionine-β-synthase (CBS) in colon cancer, resulting in an increased rate of H2S production." | 1.39 | Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. ( Chao, C; Coletta, C; Hellmich, MR; Módis, K; Papapetropoulos, A; Szabo, C; Szczesny, B, 2013) |
| "Flatus samples from patients with colon cancer and exhaled air samples from patients with lung cancer were analysed using near-edge x-ray fine adsorption structure spectroscopy and compared with those from healthy individuals." | 1.38 | Generation of gaseous sulfur-containing compounds in tumour tissue and suppression of gas diffusion as an antitumour treatment. ( Akita, K; Aoki, S; Chiba, Y; Fuji, M; Hosoya, N; Ishii, Y; Ishikawa, H; Kawai, K; Nakajima, M; Ohsaka, T; Okajima, T; Onuma, K; Saeki, Y; Sato, T; Senawongse, P; Shoun, H; Sugawara, Y; Sugiyama, S; Suzuki, T; Takahashi, M; Tsuboi, M; Urushiyama, A; Yagi, S; Yamagishi, K; Yamanaka, T, 2012) |
| " However, their long-term use is associated with adverse gastrointestinal effects." | 1.38 | NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. ( Chattopadhyay, M; Kashfi, K; Kodela, R; Olson, KR, 2012) |
| "In conclusion, NaHS induced human colon cancer cell proliferation." | 1.36 | Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21. ( Cai, WJ; Ju, LH; Wang, C; Wang, MJ; Zhu, YC, 2010) |
| "Hydrogen sulfide (H(2)S) is a prominent gaseous constituent of the gastrointestinal (GI) tract with known cytotoxic properties." | 1.33 | Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis. ( Armstrong, JS; Ming, SH; Moore, PK; Nam, OC; Rose, P; Whiteman, M, 2005) |
| "In HT-29 cells, a human colon cancer cell line, TST activity and expression were significantly increased by butyrate and by histone deacetylase inhibition, agents that promote HT-29 cell differentiation." | 1.33 | Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. ( Eggo, MC; Langman, MJ; Ramasamy, S; Singh, S; Taniere, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 9 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S | 2 |
| Li, J | 3 |
| Huang, Z | 2 |
| Yue, T | 5 |
| Zhu, J | 5 |
| Wang, X | 7 |
| Liu, Y | 6 |
| Wang, P | 6 |
| Chen, S | 6 |
| Ascenção, K | 1 |
| Lheimeur, B | 1 |
| Szabo, C | 4 |
| Tian, Q | 2 |
| Song, S | 1 |
| An, L | 2 |
| Yang, S | 2 |
| Huang, G | 1 |
| Zuo, S | 2 |
| Liu, J | 2 |
| Liu, X | 2 |
| Shi, B | 1 |
| Ren, N | 1 |
| Gu, L | 1 |
| Xu, G | 1 |
| Wang, R | 2 |
| Zhu, T | 1 |
| Zhu, Y | 1 |
| Fan, C | 1 |
| Zhao, C | 1 |
| Tian, H | 1 |
| Bu, D | 2 |
| Pan, Y | 2 |
| Saeedan, AS | 1 |
| Rastogi, S | 1 |
| Ansari, MN | 1 |
| Chang, HW | 1 |
| Frey, G | 1 |
| Liu, H | 1 |
| Xing, C | 1 |
| Steinman, L | 1 |
| Boyle, WJ | 1 |
| Short, JM | 1 |
| Feng, J | 1 |
| Ren, WX | 1 |
| Kong, F | 1 |
| Dong, YB | 1 |
| Untereiner, AA | 1 |
| Pavlidou, A | 1 |
| Druzhyna, N | 1 |
| Papapetropoulos, A | 2 |
| Hellmich, MR | 3 |
| Rui, X | 1 |
| Lin, J | 1 |
| Yang, H | 1 |
| Tao, C | 1 |
| Zuhra, K | 1 |
| Tomé, CS | 1 |
| Masi, L | 1 |
| Giardina, G | 1 |
| Paulini, G | 1 |
| Malagrinò, F | 2 |
| Forte, E | 2 |
| Vicente, JB | 2 |
| Giuffrè, A | 2 |
| Coletta, C | 1 |
| Chao, C | 1 |
| Módis, K | 1 |
| Szczesny, B | 1 |
| Hong, M | 1 |
| Tang, X | 1 |
| He, K | 1 |
| Ridlon, JM | 2 |
| Wolf, PG | 1 |
| Gaskins, HR | 1 |
| Arese, M | 1 |
| Sarti, P | 1 |
| Cao, Q | 1 |
| Zhang, L | 1 |
| Yang, G | 1 |
| Xu, C | 1 |
| Cai, WJ | 1 |
| Wang, MJ | 1 |
| Ju, LH | 1 |
| Wang, C | 1 |
| Zhu, YC | 1 |
| Yamagishi, K | 1 |
| Onuma, K | 1 |
| Chiba, Y | 1 |
| Yagi, S | 1 |
| Aoki, S | 1 |
| Sato, T | 1 |
| Sugawara, Y | 1 |
| Hosoya, N | 1 |
| Saeki, Y | 1 |
| Takahashi, M | 1 |
| Fuji, M | 1 |
| Ohsaka, T | 1 |
| Okajima, T | 1 |
| Akita, K | 1 |
| Suzuki, T | 1 |
| Senawongse, P | 1 |
| Urushiyama, A | 1 |
| Kawai, K | 1 |
| Shoun, H | 1 |
| Ishii, Y | 1 |
| Ishikawa, H | 1 |
| Sugiyama, S | 1 |
| Nakajima, M | 1 |
| Tsuboi, M | 1 |
| Yamanaka, T | 1 |
| Chattopadhyay, M | 1 |
| Kodela, R | 1 |
| Olson, KR | 1 |
| Kashfi, K | 1 |
| Rose, P | 1 |
| Moore, PK | 1 |
| Ming, SH | 1 |
| Nam, OC | 1 |
| Armstrong, JS | 1 |
| Whiteman, M | 1 |
| Kang, DJ | 1 |
| Hylemon, PB | 1 |
| Ramasamy, S | 1 |
| Singh, S | 1 |
| Taniere, P | 1 |
| Langman, MJ | 1 |
| Eggo, MC | 1 |
4 reviews available for hydrogen sulfide and Colonic Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Taurocholic acid metabolism by gut microbes and colon cancer.
Topics: Bile; Cholagogues and Choleretics; Colonic Neoplasms; Deoxycholic Acid; Detergents; Gastrointestinal | 2016 |
Bioenergetic relevance of hydrogen sulfide and the interplay between gasotransmitters at human cystathionine β-synthase.
Topics: Carbon Monoxide; Colonic Neoplasms; Cystathionine beta-Synthase; Electron Transport Complex IV; Gaso | 2016 |
Bile salt biotransformations by human intestinal bacteria.
Topics: Amidohydrolases; Amino Acid Sequence; Bacteria; Bile Acids and Salts; Biotransformation; Cholic Acid | 2006 |
1 trial available for hydrogen sulfide and Colonic Neoplasms
23 other studies available for hydrogen sulfide and Colonic Neoplasms
| Article | Year |
|---|---|
The CBS-H
Topics: Animals; Cell Proliferation; Colonic Neoplasms; Cystathionine beta-Synthase; Humans; Hydrogen Sulfid | 2022 |
Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells.
Topics: Aminooxyacetic Acid; Antineoplastic Agents; Colonic Neoplasms; Cystathionine; Cystathionine beta-Syn | 2022 |
Engineering of an endogenous hydrogen sulfide responsive smart agent for photoacoustic imaging-guided combination of photothermal therapy and chemotherapy for colon cancer.
Topics: Animals; Colonic Neoplasms; Curcumin; Hydrogen Sulfide; Mice; Photoacoustic Techniques; Photothermal | 2022 |
Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Cysteine; Hydrogen Sulfide; Immunotherapy; M | 2023 |
Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Cysteine; Hydrogen Sulfide; Immunotherapy; M | 2023 |
Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Cysteine; Hydrogen Sulfide; Immunotherapy; M | 2023 |
Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Cysteine; Hydrogen Sulfide; Immunotherapy; M | 2023 |
Theranostic Nanoplatform with Hydrogen Sulfide Activatable NIR Responsiveness for Imaging-Guided On-Demand Drug Release.
Topics: Animals; Apoptosis; Cell Proliferation; Colonic Neoplasms; Drug Liberation; Humans; Hydrogen Sulfide | 2019 |
Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Cystathionine beta- | 2019 |
Roflumilast counteracts DMH-induced preneoplastic colon damage in albino Wistar rats.
Topics: 1,2-Dimethylhydrazine; Aminopyridines; Animals; Anti-Inflammatory Agents; Antioxidants; Benzamides; | 2020 |
Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.
Topics: 5'-Nucleotidase; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neo | 2021 |
Endogenous hydrogen sulfide regulates xCT stability through persulfidation of OTUB1 at cysteine 91 in colon cancer cells.
Topics: Amino Acid Transport System y+; Animals; Cell Line, Tumor; Colonic Neoplasms; Cysteine; Deubiquitina | 2021 |
A covalent organic framework-based nanoagent for H
Topics: Animals; Colonic Neoplasms; Copper; HCT116 Cells; Humans; Hydrogen Sulfide; Infrared Rays; Metal-Org | 2021 |
[Research progress of the association of hydrogen sulfide with colorectal cancer and its associated anti-tumor drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinogenesis; Colonic Neoplasms; C | 2017 |
Drug resistance induces the upregulation of H
Topics: Aminooxyacetic Acid; Antineoplastic Agents; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cy | 2018 |
The In Situ Sulfidation of Cu
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Colonic Neoplasms; Copper; HCT116 Cells; Humans; | 2018 |
Topics: Acetylcysteine; Cell Line, Tumor; Colonic Neoplasms; Energy Metabolism; Free Radical Scavengers; Hum | 2019 |
Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer.
Topics: Animals; Cell Proliferation; Colonic Neoplasms; Cystathionine beta-Synthase; Energy Metabolism; Fema | 2013 |
Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation.
Topics: Animals; Cell Proliferation; Colonic Neoplasms; Cystathionine beta-Synthase; Energy Metabolism; Fema | 2013 |
[Effect of hydrogen sulfide on human colon cancer SW480 cell proliferation and migration in vitro].
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Humans; Hydrogen Sulfide; Su | 2014 |
Butyrate-stimulated H2S production in colon cancer cells.
Topics: Animals; Butyrates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cystathionine beta-Synthase; | 2010 |
Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21.
Topics: Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibito | 2010 |
Generation of gaseous sulfur-containing compounds in tumour tissue and suppression of gas diffusion as an antitumour treatment.
Topics: Animals; Antineoplastic Agents; Breath Tests; Cell Proliferation; Chromatography, Gas; Colonic Neopl | 2012 |
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Proliferation; Colonic Neoplasm | 2012 |
Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis.
Topics: Anticarcinogenic Agents; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Colonic Neoplasms; Hum | 2005 |
Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Colonic Neoplasms; Enzyme Activation; Gene Expression Regula | 2006 |